SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001703057-24-000024
Filing Date
2024-02-23
Accepted
2024-02-23 16:49:40
Documents
18
Period of Report
2024-02-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abcl-20240216.htm   iXBRL 8-K 26453
2 EX-99.1 a2024-02x23abcelleraanno.htm EX-99.1 6109
6 a2024-02x23abcelleraanno001.jpg GRAPHIC 116742
7 a2024-02x23abcelleraanno002.jpg GRAPHIC 233522
8 a2024-02x23abcelleraanno003.jpg GRAPHIC 41794
  Complete submission text file 0001703057-24-000024.txt   696581

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abcl-20240216.xsd EX-101.SCH 1907
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abcl-20240216_lab.xml EX-101.LAB 22785
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abcl-20240216_pre.xml EX-101.PRE 11962
20 EXTRACTED XBRL INSTANCE DOCUMENT abcl-20240216_htm.xml XML 2593
Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Filer) CIK: 0001703057 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39781 | Film No.: 24672214
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)